1EUI image
Entry Detail
PDB ID:
1EUI
Title:
ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE COMPLEX WITH URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN
Biological Source:
PDB Version:
Deposition Date:
1998-06-18
Release Date:
1999-06-22
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.27
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:URACIL-DNA GLYCOSYLASE
Chain IDs:A, B
Chain Length:228
Number of Molecules:2
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Description:URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN
Chain IDs:C, D
Chain Length:84
Number of Molecules:2
Biological Source:Bacillus phage PBS2
Primary Citation
X-ray analysis of a complex of Escherichia coli uracil DNA glycosylase (EcUDG) with a proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG.
Nucleic Acids Res. 26 4880 4887 (1998)
PMID: 9776748 DOI: 10.1093/nar/26.21.4880

Abstact

Uracil-DNA glycosylase (UDG), a key highly conserved DNA repair enzyme involved in uracil excision repair, was discovered in Escherichia coli . The Bacillus subtilis bacteriophage, PBS-1 and PBS-2, which contain dUMP residues in their DNA, express a UDG inhibitor protein, Ugi which binds to UDG very tightly to form a physiologically irreversible complex. The X-ray analysis of the E. coli UDG (Ec UDG)-Ugi complex at 3.2 A resolution, leads to the first structure elucidation of a bacterial UDG molecule. This structure is similar to the enzymes from human and viral sources. A comparison of the available structures involving UDG permits the delineation of the constant and the variable regions of the molecule. Structural comparison and mutational analysis also indicate that the mode of action of the enzyme from these sources are the same. The crystal structure shows a remarkable spatial conservation of the active site residues involved in DNA binding in spite of significant differences in the structure of the enzyme-inhibitor complex, in comparison with those from the mammalian and viral sources. Ec UDG could serve as a prototype for UDGs from pathogenic prokaryotes, and provide a framework for possible drug development against such pathogens with emphasis on features of the molecule that differ from those in the human enzyme.

Legend

Protein

Chemical

Disease

Primary Citation of related structures